Top compounds associated with response to CLDN34


Feature Type Standardized
Nominal ANOVA
mRNA tamatinib CTRPv2 pan-cancer AAC -0.038 0.3
mRNA BRD-K51490254 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA niclosamide CTRPv2 pan-cancer AAC -0.037 0.3
mRNA GSK2636771 CTRPv2 pan-cancer AAC 0.044 0.3
mRNA BRD6340 CTRPv2 pan-cancer AAC 0.035 0.3
mRNA BRD-K55473186 CTRPv2 pan-cancer AAC 0.048 0.3
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.3
mRNA neratinib CTRPv2 pan-cancer AAC 0.035 0.3
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.074 0.3
Download CSV